^
Association details:
Biomarker:No biomarker
Cancer:Uveal Melanoma
Regimen:CaT (carboplatin + paclitaxel)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
01/15/2021
Excerpt:
Recommended cytotoxic regimens include dacarbazine, paclitaxel, albumin-bound paclitaxel, or carboplatin/paclitaxel.